908 Devices Stock (NASDAQ:MASS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$8.01

52W Range

$5.03 - $9.34

50D Avg

$7.43

200D Avg

$6.83

Market Cap

$310.83M

Avg Vol (3M)

$267.98K

Beta

0.64

Div Yield

-

MASS Company Profile


908 Devices Inc. is an established technology company providing advanced mass spectrometry (Mass Spec) solutions. They develop specialized portable and benchtop instruments designed to analyze and identify unknown or hidden substances across various fields. Their products address needs in life sciences research, biopharmaceutical manufacturing, industrial biotechnology, forensic investigations, and related sectors. Key offerings include: The MX908, a handheld, battery-operated Mass Spec device capable of rapid on-site detection and identification of unknown gaseous, liquid, and solid materials. The Rebel, a compact desktop analyzer that delivers real-time data concerning the extracellular environment within bioprocesses. The ZipChip solution, a high-resolution, user-friendly separation platform engineered to optimize the preparation and analysis of samples for Mass Spec. With operations spanning the globe, 908 Devices Inc. serves markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was established in 2012 and is based in Boston, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

246

IPO Date

Dec 18, 2020

Website

MASS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Contract$117.00K$317.00K$370.00K
Device Sales$36.66M$35.99M$33.38M
Recurring$19.42M$23.32M$16.48M
Product and service revenue$6.99M$59.63M$49.86M

Fiscal year ends in Dec 25 | Currency in USD

MASS Financial Summary


Dec 25Dec 24Dec 23
Revenue$56.20M$59.63M$50.23M
Operating Income$-39.42M$-76.72M$-42.76M
Net Income$19.49M$-72.21M$-36.40M
EBITDA$-21.50M$-43.88M$-40.27M
Basic EPS$0.54$-2.12$-1.13
Diluted EPS$0.54$-2.12$-1.13

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 06, 26 | 12:00 AM
Q4 25Mar 03, 26 | 8:30 AM
Q3 25Nov 10, 25 | 8:30 AM

Peer Comparison


TickerCompany
SNWVSANUWAVE Health, Inc.
SENSSenseonics Holdings, Inc.
QTRXQuanterix Corporation
CERSCerus Corporation
SGHTSight Sciences, Inc.
ACRSAclaris Therapeutics, Inc.
NNOXNano-X Imaging Ltd.
NPCENeuroPace, Inc.
CAPRCapricor Therapeutics, Inc.
CVRXCVRx, Inc.